Precision Dosing for Individualized Drug Therapy

This direction is merged into another direction: inter-patient pharmacokinetic variability. Its last version stays readable and citable here.

Version 1 of 133 papers39 conceptsfrozen 2026-10-04

The "one-size-fits-all" model of medicine is increasingly recognized as a dangerous oversimplification. In conventional clinical practice, drugs are often prescribed at standardized dosages based on population averages. However, as Konrad J. Karczewski and Roxana Daneshjou argue in Pharmacogenomics, this trial-and-error approach ignores the unique genetic and biological blueprints that dictate how an individual responds to medication, leading to either therapeutic failure or life-threatening toxic reactions.

Precision dosing seeks to replace these static regimens with dynamic, data-driven strategies that account for the vast inter-individual variability in drug metabolism and response.

The Drivers of Biological Variability

Why does the same dose of a drug produce vastly different concentrations in different people? The answer lies in a set of physiological "covariates" that influence pharmacokinetics (PK)—how the body processes a drug—and pharmacodynamics (PD)—how the drug affects the body.

Research by Jingfeng Bi and colleagues in Population pharmacokinetics of peginterferon α2a demonstrates that Body Mass Index (BMI) and kidney function (creatinine clearance) are primary drivers of drug distribution and clearance. Similarly, Huiqing Hou found that age and smoking status significantly impact how quickly patients reach therapeutic levels of warfarin in Related factors and safety of reaching the therapeutic target of warfarin.

When these factors are ignored, the results are unpredictable. For instance, Hong Jiang and Wei Yan showed that for the cancer drug anlotinib, maintaining a specific trough plasma concentration is critical for efficacy, yet fixed-dose regimens result in massive variability that leaves many patients undertreated (Association between anlotinib trough plasma concentration and treatment outcomes).

Modeling the Individual

To move beyond averages, researchers use Population Pharmacokinetic (PPK) modeling. These models treat a patient population as a distribution rather than a single point, identifying the mathematical relationships between clinical variables and drug behavior.

  1. Covariate Analysis: By identifying which factors (like renal function or liver health) drive drug clearance, researchers like Yueliang Xie can optimize dosages for critically ill patients who might otherwise receive insufficient treatment (Population pharmacokinetics of intravenous colistin sulfate).
  2. Therapeutic Drug Monitoring (TDM): This involves measuring drug levels in a patient's blood and adjusting the dose in real-time. Yujin Lim suggests that even annual monitoring can significantly improve outcomes for stable patients by balancing efficacy with the risk of "pharmacokinetic failure" (Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease).
  3. Simulation-Based Dosing: Tools like Monte Carlo simulations allow clinicians to predict the probability of a dosing regimen reaching a therapeutic target before the drug is even administered, as seen in neonatal vancomycin studies by Kai Zhao (Vancomycin Dosing Regimens based on Monte Carlo Simulation).

From Static Schedules to Closed-Loop Control

The most advanced frontier of precision dosing involves treating treatment as a sequential decision-making problem. Olga Teplytska and Jan Hasenauer highlight the role of Reinforcement Learning (RL) in oncology, where algorithms learn to maximize tumor shrinkage while minimizing toxicity by adapting to the patient's evolving response (Machine Learning Methods for Precision Dosing in Anticancer Drug Therapy).

This shift requires moving from "open-loop" scheduling (where a plan is set at the start) to "closed-loop" control (where the treatment is adjusted based on feedback). Dirk Husmeier and L. Mihaela Păun emphasize that failing to model this feedback loop—where the treatment itself changes the patient's physiology—can lead to systematic errors in risk prediction (Closed-loop effects in cardiovascular clinical decision support).

Digital Twins and the Future of Delivery

The ultimate realization of this field may be the Digital Twin. As proposed by Bergþór Björnsson and colleagues, a digital twin is a high-resolution computational replica of a patient. By simulating thousands of drug treatments on this replica, clinicians can identify the optimal therapy without the risks of real-world trial-and-error (Digital twins to personalize medicine).

Complementing these digital models are new manufacturing technologies like 3D printing. Devanshi Jadaun and others explore how additive manufacturing can produce customized dosages and complex release profiles tailored to an individual's specific needs, moving the pharmacy from mass production to bespoke fabrication (A REVIEW ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS).

By integrating genetic data, pharmacokinetic modeling, and machine learning, the medical field is transitioning toward a future where the dose is as unique as the patient.

Papers in this version

History & citationVersion 1 · 2026-10-04

Merged into another direction · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_precision_dosing_for_individualized_drug_597b7d3a,
  title = {Precision Dosing for Individualized Drug Therapy},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/precision-dosing-for-individualized-drug-therapy/rdr_597b7d3aef8440678bf358eebb0bcf48},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_precision_dosing_for_individualized_drug_597b7d3a_v1,
  title = {Precision Dosing for Individualized Drug Therapy},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/precision-dosing-for-individualized-drug-therapy/rdr_597b7d3aef8440678bf358eebb0bcf48/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}